Atherosclerosis
Volume 176, Issue 2 , Pages 361-370 , October 2004

Associations of plasma homocysteine and the methylenetetrahydrofolate reductase C677T polymorphism with carotid intima media thickness among South Asian, Chinese and European Canadians

  • Linda E. Kelemen

      Affiliations

    • Department of Health Sciences Research, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN, USA
    • Corresponding Author InformationCorresponding author.
    • ,
  • Sonia S. Anand

      Affiliations

    • Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, Ont., Canada
    • Department of Medicine, McMaster University, Hamilton, Ont., Canada
    • ,
  • Robert A. Hegele

      Affiliations

    • Blackburn Cardiovascular Genetics Laboratory, Robarts Research Institute, London, Ont., Canada
    • ,
  • Meir J. Stampfer

      Affiliations

    • Departments of Epidemiology and Nutrition, Harvard School of Public Health, Boston, MA, USA
    • Department of Medicine, Channing Laboratory, Harvard Medical School, Brigham and Women’s Hospital, Boston, MA, USA
    • ,
  • Bernard Rosner

      Affiliations

    • Department of Medicine, Channing Laboratory, Harvard Medical School, Brigham and Women’s Hospital, Boston, MA, USA
    • ,
  • Walter C. Willett

      Affiliations

    • Departments of Epidemiology and Nutrition, Harvard School of Public Health, Boston, MA, USA
    • Department of Medicine, Channing Laboratory, Harvard Medical School, Brigham and Women’s Hospital, Boston, MA, USA
    • ,
  • Patricia A. Montague

      Affiliations

    • Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, Ont., Canada
    • Department of Medicine, McMaster University, Hamilton, Ont., Canada
    • ,
  • Eva Lonn

      Affiliations

    • Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, Ont., Canada
    • Department of Medicine, McMaster University, Hamilton, Ont., Canada
    • ,
  • Vladimir Vuksan

      Affiliations

    • Clinical Nutrition and Risk Factor Modification Centre, St. Michael’s Hospital, Toronto, Ont., Canada
    • Faculty of Medicine, University of Toronto, Toronto, Ont., Canada
    • ,
  • Koon K. Teo

      Affiliations

    • Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, Ont., Canada
    • Department of Medicine, McMaster University, Hamilton, Ont., Canada
    • ,
  • Sudarshan Devanesen

      Affiliations

    • Faculty of Medicine, University of Toronto, Toronto, Ont., Canada
    • ,
  • Salim Yusuf

      Affiliations

    • Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, Ont., Canada
    • Department of Medicine, McMaster University, Hamilton, Ont., Canada
    • for the SHARE Investigators.

Received 1 December 2003 ,Revised 13 May 2004 ,Accepted 1 June 2004.

References 

  1. Sheth T, Nair C, Nargundkar M, et al.  Cardiovascular and cancer mortality among Canadians of European South Asian and Chinese origin from 1979 to 1993: an analysis of 1.22 million deaths. Can Med Assoc J. 1999;161:132–138
  2. Anand SS, Yusuf S, Vuksan V, et al.  For the SHARE Investigators. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet. 2000;356:279–284
  3. Jacques PF, Bostom AG, Wilson PWF, et al.  Determinants of plasma total homocysteine concentration in the Framingham offspring cohort. Am J Clin Nutr. 2001;73:613–621
  4. Graham IM, Daly LE, Refsum HM, et al.  Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA. 1997;277:1775–1781
  5. Hopkins PN, Wu LL, Wu J, et al.  Higher plasma homocyst(e)ine and increased susceptibility to adverse effects of low folate in early familial coronary artery disease. Arterioscler Thromb Vasc Biol. 1995;15:1314–1320
  6. Dalery K, Lussier-Cacan S, Selhub J, et al.  Homocysteine and coronary artery disease in French Canadian subjects: relation with vitamins B12, pyridoxal phosphate, and folate. Am J Cardiol. 1995;75:1107–1111
  7. Robinson K, Mayer EL, Miller DP, et al.  Hyperhomocysteinemia and low pyridoxal phosphate. Circulation. 1995;92:2825–2830
  8. Malinow MR, Ducimetiere P, Luc G, et al.  Plasma homocyst(e)ine levels and graded risk for myocardial infarction: findings in two populations at contrasting risk for coronary heart disease. Atherosclerosis. 1996;126:27–34
  9. Verhoef P, Kok FJ, Kruyssen DACM, et al.  Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 1997;17:989–995
  10. Malinow MR, Nieto FJ, Szklo M, et al.  Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The atherosclerosis risk in communities study. Circulation. 1993;87:1107–1113
  11. Selhub J, Jacques PF, Bostom AG, et al.  Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med. 1995;332:286–291
  12. Ridker PM, Manson JE, Buring JE, et al.  Homocysteine and risk of cardiovascular disease among postmenopausal women. JAMA. 1999;281:1817–1821
  13. Arneson E, Refsum H, Bonaa KH, et al.  Serum total homocysteine and coronary heart disease. Int J Epidemiol. 1995;24:704–709
  14. Nygard O, Nordrehaug JE, Refsum H, et al.  Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med. 1997;337:230–236
  15. Petri M, Roubenoff R, Dalal GE, et al.  Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. Lancet. 1996;348:1120–1124
  16. Stampfer MJ, Malinow MR, Willett WC, et al.  A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA. 1992;268:877–881
  17. Wald NJ, Watt HC, Law MR, et al.  Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention. Arch Int Med. 1998;158:862–867
  18. Bostom AG, Silbershatz H, Rosenberg IH, et al.  Nonfasting plasma total homocysteine levels and all cause and cardiovascular disease mortality in elderly Framingham men and women. Arch Int Med. 1999;159:1077–1080
  19. Whincup PH, Refsum H, Perry IJ, et al.  Serum total homocysteine and coronary heart disease: prospective study in middle aged men. Heart. 1999;82:448–454
  20. Bots ML, Launer LJ, Lindemans J, et al.  Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam study. Arch Int Med. 1999;159:38–44
  21. Folsom AR, Nieto J, McGovern PG, et al.  Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms and B vitamins. The atherosclerosis risk in communities (ARIC) study. Circulation. 1998;98:204–210
  22. Ubbink JB, Fehily AM, Pickering J, et al.  Homocysteine and ischemic heart disease in the Caerphilly cohort. Atherosclerosis. 1998;140:349–356
  23. Chasen-Taber L, Selhub J, Rosenberg IH, et al.  A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians. J Am Coll Nutr. 1996;15:136–143
  24. Verhoef P, Hennekens CH, Allen RH, et al.  Plasma total homocysteine and risk of angina pectoris with subsequent coronary artery bypass surgery. Am J Cardiol. 1997;79:799–801
  25. Alfthan G, Pekkanen J, Jauhiainen M, et al.  Relation of serum homocysteine and lipoprotein (a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis. 1994;106:9–19
  26. Stehouwer CD, Weijenberg MP, van den Berg M, et al.  Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men: a 10-year follow-up. Arterioscler Thromb VascBiol. 1998;18:1895–1901
  27. Evans RW, Shaten J, Hempel JD, et al.  for the MRFIT Research Group. Homocyst(e)ine and risk of cardiovascular disease in the multiple risk factor intervention trial. Arterioscler Thromb Vasc Biol. 1997;17:1947–1953
  28. Frosst P, Blom HJ, Milos R, et al.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genet. 1995;10:111–113
  29. Kang SS, Zhou J, Wong PWK, et al. Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase, Am J Hum Genet 1988; 414–21.
  30. Christensen B, Frosst P, Lussier-Cacan S, et al.  Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease. Arterioscler Thromb Vasc Biol. 1997;17:569–573
  31. Jacques PF, Bostom AG, Williams RR, et al.  Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 1996;93:7–9
  32. Ma J, Stampfer MJ, Hennekens CH, et al.  Methylene tetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation. 1996;94:2410–2416
  33. Chambers J, Obeid OA, Refsum H, et al.  Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. Lancet. 2000;355:523–527
  34. Saw S-M, Yuan J-M, Ong C-N, et al.  Genetic, dietary, and other lifestyle determinants of plasma homocysteine concentrations in middle-aged and older Chinese men and women in Singapore. Am J Clin Nutr. 2001;73:232–239
  35. Sheth T, Nargundkar M, Chagani K, et al.  Classifying ethnicity utilising the Canadian Mortality Data Base. Ethn Health. 1997;29:287–295
  36. Harland JO, White M, Bhopal RS, et al.  Identifying Chinese populations in the UK for epidemiological research: experience of a name analysis of the FSHA register. Public Health. 1997;111:331–337
  37. Anand SS, Yusuf S, Vuksan V, et al.  For the SHARE Investigators. The Study of Health Assessment and Risk in Ethnic groups (SHARE): rationale and design. Can J Cardiol. 1998;14:1349–1357
  38. Fortin L, Genest J. Measurement of homocysteine in the prediction of arteriosclerosis. Clin Biochem. 1995;28:155–162
  39. Chambless LE, Heiss G, Folsom AR, et al.  Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the atherosclerosis risk in communities (ARIC) study 1987–1993. Am J Epidemiol. 1997;146:483–494
  40. Kelemen LE, Anand SS, Vuksan V, et al.  Development and evaluation of cultural food frequency questionnaires for South Asians, Chinese and Europeans in North America. J Am Diet Assoc. 2003;103:1178–1184
  41. Spence JD, Malinow MR, Barnett PA, et al.  Plasma homocyst(e)ine concentration, but not MTHFR genotype, is associated with variation in carotid plaque area. Stroke. 1999;30:969–973
  42. Jacques PF, Sulsky SI, Sadowski JA, et al.  Comparison of micronutrient intake measured by a dietary questionnaire and biochemical indicators of micronutrient status. Am J Clin Nutr. 1993;57:182–189
  43. Willett WC, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol. 1986;124:17–27
  44. Kleinbaum DG, Kupper LL, Muller KE, et al. One-way analysis of variance. Applied Regression Analysis and Other Multivariable Methods. 3rd ed. Duxbury Press: Pacific Grove; 1998.
  45. Guenther BD, Sheppard CA, Tran P, et al.  The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia. Nature Structural Biol. 1999;6:359–365
  46. Kolonel LN, Henderson BE, Hankin JH, et al.  A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol. 2000;151:346–357
  47. Hughes K, Ong C-N. Homocysteine, folate, vitamin B12, and cardiovascular risk in Indians, Malays, and Chinese in Singapore. J Epidemiol Community Health. 2000;54:31–34
  48. Canada Gazette Part II, Ottawa, Canada. 25 November 1998;132(24):3026–40. http://canadagazette.gc.ca/partII/1998/19981125/pdf/g2-13224.pdf. Accessed 20 April 2004.
  49. Klerk M, Verhoef P, Clarke R, et al.  For the MTHFR Studies Collaboration. MTHFR 677C → T polymorphism and risk of coronary heart disease. JAMA. 2002;288:2023–2031
  50. The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke. A meta-analysis. JAMA 2002;288:2015–22.
  51. McQuillan BM, Beilby JP, Nidorf M, et al.  Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS). Circulation. 1999;99:2383–2388

PII: S0021-9150(04)00289-8

doi: 10.1016/j.atherosclerosis.2004.06.003

Atherosclerosis
Volume 176, Issue 2 , Pages 361-370 , October 2004

Article Tools